Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Accenture
Cipla
Chinese Patent Office
US Department of Justice
Harvard Business School
Merck
Chubb
Boehringer Ingelheim

Generated: October 23, 2017

DrugPatentWatch Database Preview

Aqua Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for AQUA PHARMS, and when can generic versions of AQUA PHARMS drugs launch?

AQUA PHARMS has eleven approved drugs.

There are twelve US patents protecting AQUA PHARMS drugs.

There are one hundred and forty-seven patent family members on AQUA PHARMS drugs in thirty-seven countries and fourteen supplementary protection certificates in nine countries.

Summary for Applicant: Aqua Pharms

International Patents:147
US Patents:12
Tradenames:11
Ingredients:9
NDAs:11
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aqua Pharms Llc
ACTICLATE
doxycycline hyclate
TABLET;ORAL205931-002Jul 25, 2014ABRXYesYes► Subscribe► Subscribe► Subscribe
Aqua Pharms Llc
ALTABAX
retapamulin
OINTMENT;TOPICAL022055-001Apr 12, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms
MONODOX
doxycycline
CAPSULE;ORAL050641-003Oct 18, 2006ABRXYesNo► Subscribe► Subscribe► Subscribe
Aqua Pharms
CORDRAN
flurandrenolide
OINTMENT;TOPICAL012806-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Aqua Pharms Llc
ACTICLATE
doxycycline hyclate
TABLET;ORAL205931-001Jul 25, 2014ABRXYesNo► Subscribe► Subscribe► Subscribe
Aqua Pharms
XOLEGEL
ketoconazole
GEL;TOPICAL021946-001Jul 28, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms
MONODOX
doxycycline
CAPSULE;ORAL050641-001Dec 29, 1989ABRXYesYes► Subscribe► Subscribe► Subscribe
Aqua Pharms
VERDESO
desonide
AEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms
VERDESO
desonide
AEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes► Subscribe► SubscribeY ► Subscribe
Aqua Pharms Llc
ALTABAX
retapamulin
OINTMENT;TOPICAL022055-001Apr 12, 2007RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Aqua Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aqua Pharms
SOLAGE
mequinol; tretinoin
SOLUTION;TOPICAL020922-001Dec 10, 1999► Subscribe► Subscribe
Aqua Pharms Llc
VELTIN
clindamycin phosphate; tretinoin
GEL;TOPICAL050803-001Jul 16, 2010► Subscribe► Subscribe
Aqua Pharms
SOLAGE
mequinol; tretinoin
SOLUTION;TOPICAL020922-001Dec 10, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Aqua Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,263,580Vitamin formulation► Subscribe
6,281,226 Pleuromutilin derivatives as antimicrobials► Subscribe
6,238,683 Anhydrous topical skin preparations► Subscribe
RE39128Pleuromutilin derivatives as antimicrobials► Subscribe
8,629,128Vitamin formulation► Subscribe
8,298,515Vitamin formulation► Subscribe
8,449,867Microemulsion and sub-micron emulsion process and compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Aqua Pharms Drugs

Country Document Number Estimated Expiration
Japan4227729► Subscribe
Israel135811► Subscribe
European Patent Office1917072► Subscribe
World Intellectual Property Organization (WIPO)2006024095► Subscribe
Brazil9913154► Subscribe
Japan2012020998► Subscribe
Israel181632► Subscribe
Japan2009040789► Subscribe
Canada2611147► Subscribe
European Patent Office1313442► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Aqua Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2007 00052Denmark► Subscribe
401Luxembourg► SubscribePRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
C/GB07/061United Kingdom► SubscribePRODUCT NAME: RETAPAMULIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/07/390/001 20070524; UK EU/1/07/390/002 20070524; UK EU/1/07/390/003 20070524; UK EU/1/07/390/004 20070524
372Luxembourg► Subscribe91372, EXPIRES: 20220524
2013025,C1304992Lithuania► SubscribePRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
1028961/01Switzerland► SubscribePRODUCT NAME: RETAPAMULIN; REGISTRATION NUMBER/DATE: SWISSMEDIC 58641 04.08.2009
2013 00053Denmark► SubscribePRODUCT NAME: CLINDAMYCIN (SOM CLINDAMYCIN PHOSPHATE) OG TRETINOIN; NAT. REG. NO/DATE: 48954 20130416; FIRST REG. NO/DATE: IE PA1332/043/001 20130322
1304992/01Switzerland► SubscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
00617Netherlands► SubscribePRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
6Finland► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Harvard Business School
Novartis
Queensland Health
Fish and Richardson
Farmers Insurance
McKinsey
Teva
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot